Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Schuler

Showing results (31-40 of 188) with videos related to

Pageof 19
Sort By:
Journal of the American Academy of Dermatology|March 12, 2005
Infliximab in the treatment of moderate to severe atopic dermatitisArnd Jacobi, Christian Antoni, Bernhard Manger, et al.
European Journal of Dermatology : EJD|May 20, 2006
Delayed response of oral pemphigus vulgaris to rituximab treatmentAndrea Niedermeier, Petra Wörl, Sandra Barth, et al.
Dermatology (Basel, Switzerland)|July 4, 2015
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma PatientsMirjam Baiter, Gerold Schuler, Arndt Hartmann, et al.
Cytotherapy|November 1, 2019
Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccinesUgur Uslu, Michael Erdmann, Manuel Wiesinger, et al.
Oncoimmunology|July 23, 2014
Immunogenic and tolerogenic effects of the chimeric IL-2-diphtheria toxin cytocidal agent Ontak<sup>®</sup> on CD25<sup>+</sup> cellsManfred B Lutz, Andreas S Baur, Beatrice Schuler-Thurner, et al.
European Journal of Dermatology : EJD|August 29, 2006
Late syphilis mimicking a pseudolymphoma of the skinCornelia Erfurt, Matthias Lueftl, Miklos Simon, et al.
Oncotarget|July 11, 2018
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patientsMichael Constantin Kirchberger, Alvaro Moreira, Michael Erdmann, et al.
Cancers|May 30, 2019
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor TransferBianca Simon, Dennis C Harrer, Beatrice Schuler-Thurner, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapyTobias Riet, Astrid Holzinger, Jan Dörrie, et al.
Facial Plastic Surgery : FPS|December 31, 2019
Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial TumorsMichael C Kirchberger, Markus V Heppt, Gerold Schuler, et al.
Pageof 19

Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Journal of the American Academy of Dermatology|March 12, 2005
Infliximab in the treatment of moderate to severe atopic dermatitisArnd Jacobi, Christian Antoni, Bernhard Manger, et al.
European Journal of Dermatology : EJD|May 20, 2006
Delayed response of oral pemphigus vulgaris to rituximab treatmentAndrea Niedermeier, Petra Wörl, Sandra Barth, et al.
Dermatology (Basel, Switzerland)|July 4, 2015
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma PatientsMirjam Baiter, Gerold Schuler, Arndt Hartmann, et al.
Cytotherapy|November 1, 2019
Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccinesUgur Uslu, Michael Erdmann, Manuel Wiesinger, et al.
Oncoimmunology|July 23, 2014
Immunogenic and tolerogenic effects of the chimeric IL-2-diphtheria toxin cytocidal agent Ontak<sup>®</sup> on CD25<sup>+</sup> cellsManfred B Lutz, Andreas S Baur, Beatrice Schuler-Thurner, et al.
European Journal of Dermatology : EJD|August 29, 2006
Late syphilis mimicking a pseudolymphoma of the skinCornelia Erfurt, Matthias Lueftl, Miklos Simon, et al.
Oncotarget|July 11, 2018
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patientsMichael Constantin Kirchberger, Alvaro Moreira, Michael Erdmann, et al.
Cancers|May 30, 2019
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor TransferBianca Simon, Dennis C Harrer, Beatrice Schuler-Thurner, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapyTobias Riet, Astrid Holzinger, Jan Dörrie, et al.
Facial Plastic Surgery : FPS|December 31, 2019
Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial TumorsMichael C Kirchberger, Markus V Heppt, Gerold Schuler, et al.
Pageof 19